BREAKTHROUGH RESEARCH USING THE PARSORTIX SYSTEM HIGHLIGHTS POTENTIAL TO TRANSFORM CANCER TREATMENT BY SUPPRESSING CANCER METASTASIS https://www.otcmarkets.com/stock/ANPCY/quote https://otp.tools.investis.com/clie...regulatory-story.aspx?cid=1560&newsid=1223545
The shares shot up to 75p then fell back to 53p. Still got potential for the future but typical new medical technology company - volatile! Not for widows and orphans as they say
The shares have fallen back again but the FDA trial has nearly finished and hopefully FDA approval is on its way. The fact another biotech share had its FDA approval delayed (resulting in the shares falling for 40p+ to 6p) is not helping sentiment.
